13F filing recap · Q3 2018

What did ValueAct Capital buy in Q3 2018?

Reported stock-position changes between this filing and the previous one.

Stock value

$10.17B

Positions

Estimated turnover

28.1%

Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.

New positions

BHCBausch Health Companies Inc.$462.91Mreported value+18.03M shares XRAYDentsply Sirona Inc.$83.03Mreported value+2.20M shares HEHawaiian Electric Industries, Inc.$42.61Mreported value+1.20M shares STRAStrategic Education, Inc.$33.18Mreported value+242.1K shares SYMCSymantec Corporation$10.64Mreported value+500.0K shares

Increased positions

CCitigroup Inc$1.88Breported value+1.05M shares+4.2%STXSeagate Technology Holdings Plc$1.25Breported value+3.99M shares+17.8%MSMorgan Stanley$969.14Mreported value+2.10M shares+11.2%SLMSlm Corp$436.90Mreported value+1.58M shares

Reduced positions

AWIArmstrong World Industries, Inc.$363.65Mreported value-1.63M shares-23.8%

Exited positions

FOXATwenty-First Century Fox, Inc.$1.41Bprior reported value-28.63M shares-100.0%VRXValeant Pharmaceuticals International, Inc.$419.09Mprior reported value-18.03M shares-100.0%STRAStrategic Education, Inc.$21.86Mprior reported value-193.5K shares-100.0%